April 4, 2016

Timmerman Report

How Can Migraine Drugmakers Avoid the PCSK9 Debacle?

By Luke Timmerman

One of the big ideas in biotech today is that you can prevent severe, chronic migraineheadaches. This story has a lot of juicy ingredients: intriguing biology, bona fide medical value, and a potentially broad impact on millions of people. But if the drugmakers in this emergingcategory overplay their hand, and don’t paycareful attention to the new drug pricingreality, it could become a train wreck.

read full article >